This review focuses on a somewhat unexplored strand of regenerative medicine, that is in
situ tissue engineering. In this approach manufactured scaffolds are implanted in the injured …

Cardiovascular disease is the most common cause of death in the world. In severe cases,
replacement or revascularization using vascular grafts are the treatment options. While …

Tissue engineering is an emerging means for resolving the problems of tissue repair and
organ replacement in regenerative medicine. Insufficient supply of nutrients and oxygen to …

Current clinical treatment strategies for the bypassing of small diameter (< 6 mm) blood
vessels in the management of cardiovascular disease frequently fail due to a lack of suitable …

Biopolymers are widely available, low-/nontoxic, biodegradable, biocompatible, chemically
versatile, and inherently functional, making them highly potential for a broad range of …

A variety of engineered materials have gained acceptance in orthopedic practice as
substitutes for autologous bone grafts, although the regenerative efficacy of these …

Blood vessel damage resulting from trauma or diseases presents a serious risk of morbidity
and mortality. Although synthetic vascular grafts have been successfully commercialized for …

Large bone defects remain an unsolved clinical challenge because of the lack of effective
vascularization in newly formed bone tissue. 3D bioprinting is a fabrication technology with …

The increased demands of small-diameter vascular grafts (SDVGs) globally has forced the
scientific society to explore alternative strategies utilizing the tissue engineering …

Cardiovascular diseases, especially ones involving narrowed or blocked blood vessels with
diameters smaller than 6 millimeters, are the leading cause of death globally. Vascular grafts …